EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discovery of TRPV4-Targeting Small Molecules with Anti-Influenza Effects Through Machine Learning and Experimental Validation

Yan Sun, Jiajing Wu, Beilei Shen, Hengzheng Yang, Huizi Cui, Weiwei Han iD, Rongbo Luo, Shijun Zhang, He Li iD, Bingshuo Qian, Lingjun Fan, Junkui Zhang und 4 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26031381 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Yan Sun und 15 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong 030801, China. Hauptthemen laut MEDLINE: TRPV Cation Channels, Antiviral Agents, Machine Learning, Small Molecule Libraries. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yuwei Gao, Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transient receptor potential vanilloid 4 (TRPV4) is a calcium-permeable cation channel critical for maintaining intracellular Ca2+ homeostasis and is essential in regulating immune responses, metabolic processes, and signal transduction. Recent studies have shown that TRPV4 activation enhances influenza A virus infection, promoting viral replication and transmission. However, there has been limited exploration of antiviral drugs targeting the TRPV4 channel. In this study, we developed the first machine learning model specifically designed to predict TRPV4 inhibitory small molecules, providing a novel approach for rapidly identifying repurposed drugs with potential antiviral effects. Our approach integrated machine learning, virtual screening, data analysis, and experimental validation to efficiently screen and evaluate candidate molecules. For high-throughput virtual screening, we employed computational methods to screen open-source molecular databases targeting the TRPV4 receptor protein. The virtual screening results were ranked based on predicted scores from our optimized model and binding energy, allowing us to prioritize potential inhibitors. Fifteen small-molecule drugs were selected for further in vitro and in vivo antiviral testing against influenza. Notably, glecaprevir and everolimus demonstrated significant inhibitory effects on the influenza virus, markedly improving survival rates in influenza-infected mice (protection rates of 80% and 100%, respectively). We also validated the mechanisms by which these drugs interact with the TRPV4 channel. In summary, our study presents the first predictive model for identifying TRPV4 inhibitors, underscoring TRPV4 inhibition as a promising strategy for antiviral drug development against influenza. This pioneering approach lays the groundwork for future clinical research targeting the TRPV4 channel in antiviral therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TRPV Cation ChannelsAntiviral AgentsMachine LearningSmall Molecule LibrariesOrthomyxoviridae InfectionsInfluenza, HumanAnimalsMiceHumansMolecular Docking SimulationDrug DiscoveryInfluenza A virus

Stichwörter der Autor:innen

H1N1TRPV4anti-influenzamachine learningmolecular dockingrepurposing drugs

Substanzen

TRPV Cation ChannelsAntiviral AgentsSmall Molecule LibrariesTRPV4 protein, human

Autor:innen und Institutionen

  • College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong 030801, China.
  • State Key Laboratory of Pathogen and Biosecurity, Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun 130122…
  • Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Science, Jilin University, Changchun 130012, China.
  • Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou 225009, China.

ORCID-Profile: Weiwei Han, He Li

Förderung

  • Yuwei Gao
  • Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences

Zitieren

APA

Sun, Y., Wu, J., Shen, B., Yang, H., Cui, H., Han, W., Luo, R., Zhang, S., Li, H., Qian, B., Fan, L., Zhang, J., Wang, T., Xia, X., Yan, F., & Gao, Y. (2025). Discovery of TRPV4-Targeting Small Molecules with Anti-Influenza Effects Through Machine Learning and Experimental Validation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26031381

Vancouver

Sun Y, Wu J, Shen B, Yang H, Cui H, Han W, et al. Discovery of TRPV4-Targeting Small Molecules with Anti-Influenza Effects Through Machine Learning and Experimental Validation. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26031381

BibTeX
@article{Sun2025,
  author = {Sun, Yan and Wu, Jiajing and Shen, Beilei and Yang, Hengzheng and Cui, Huizi and Han, Weiwei and Luo, Rongbo and Zhang, Shijun and Li, He and Qian, Bingshuo and Fan, Lingjun and Zhang, Junkui and Wang, Tiecheng and Xia, Xianzhu and Yan, Fang and Gao, Yuwei},
  title = {Discovery of TRPV4-Targeting Small Molecules with Anti-Influenza Effects Through Machine Learning and Experimental Validation},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26031381}
}
Kostenlos starten →